A Unique Health and Research Fair on the CU Anschutz Medical Campus

This year, the University of Colorado Anschutz Medical Campus has teamed up with 365Health to host a health and research fair on Saturday, November 5, from 9 a.m. to noon. The fair will provide community members in Aurora and surrounding areas with the opportunity to get free or low-cost health screenings, blood work, COVID and flu vaccines, medical advice, attend cooking demonstrations and much more.

The fair will also highlight dozens of innovative research studies happening on the CU Anschutz Medical Campus and provide the opportunity to meet with researchers who are studying things like asthma, brain health, weight loss, exercise and more. Attendees can also sign-up to participate in important research studies – many of which provide compensation – while learning how research can improve their health.

The fair will showcase over 25 different research opportunities, including a study about the impact of exercise on diabetes and another that seeks to develop better treatments for long COVID, to name a few. Below is more information on both of those studies. 

The fair is free to attend and will take place at the Anschutz Health and Wellness Center, located at 12348 E Montview Blvd, Aurora, CO 80045.

Exercise & Diabetes Study:
The BURST2D study is researching whether small, frequent bouts of walking throughout the day improve metabolic health compared to 1 larger walking bout. CU Anschutz is recruiting people with prediabetes or altered blood glucose (via fasting glucose, A1C, or OGTT – all completed during screening visits post-consent) who have a BMI between 25-40, sit for at least 6 hours per day, and do not regularly exercise more than 150 minutes per week. The study provides medical testing, metabolic testing, exercise coaching, and a FitBit for free to all participants, in addition to compensation up to $1350 for completion of study visits.

COVID Recovery Study:
The RECOVER Initiative aims to understand how people recover from a COVID infection and why some people do not fully recover and develop Long COVID or PASC (post-acute sequelae of SARS-CoV-2). The study is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without PASC symptoms will be followed to identify risk factors and occurrence of PASC. The study is recruiting a variety of people who have had COVID (and about 2,500 who have not).